ID
24461
Beschrijving
Visit 2 General Medical History - Physical Examination Findings form Study ID: 208127/125 Clinical Study ID: 208127/125 (Ext-HAB-038 Month 90) Study Title: A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A / hepatitis B vaccine in healthy children between 6 and 15 years of age. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B
Trefwoorden
Versies (1)
- 01-08-17 01-08-17 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
1 augustus 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Visit 2 General Medical History Biologicals HepA/HepB vaccine 208127/125
Visit 2 General Medical History Biologicals HepA/HepB vaccine 208127/125
Beschrijving
General Medical History
Alias
- UMLS CUI-1
- C0262926
Beschrijving
if Yes, please complete the medication section
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013216
Beschrijving
If Yes, provide one diagnosis per line. In case of unclear diagnosis provide the significant signs or symptoms on separate lines.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0973444
- UMLS CUI [2]
- C0543467
Beschrijving
DIAGNOSIS / SIGNS AND SYMPTOMS
Alias
- UMLS CUI-1
- C0011900
- UMLS CUI-3
- C0037088
Similar models
Visit 2 General Medical History Biologicals HepA/HepB vaccine 208127/125
C0543467 (UMLS CUI [2])
C0037088 (UMLS CUI-3)